I just read an article on a business related Website, PR-insider.com: New Study, “Pipeline Insight: Lymphomas, Multiple Myeloma & Myelodysplastic Syndromes”, Published.
According to the article, “There are currently 66 drugs under development for multiple myeloma, of which 8 are in late phase development.” The balance of the article discusses which drug company stock to buy. No specifics were available without purchasing access. What interested me were the advances being made, not only against multiple myeloma, but in the lymphomas as well—over 100 drugs are in the developmental pipeline for various lymphomas, according to the article.
The future looks bright for those of us in the blood cancer fraternity. More research, more studies = more time for most of us to spend with our friends and families.
Feel good and keep smiling! Pat